<b>Gapping up <br/>In reaction to strong earnings/guidance:</b><br/><br/>DDR +8%, MERC +8%, MULE +7.3%, (light volume), BL +5.9%, CTT +4.8%, IRM +4.7%, ENB +4.2%, NWL +4%, AIRG +3.6%, NEXA +3.1%, KO +2.9%, OZM +2.9%, CLD +2.8%, CRAY +2.5%, SNBR +2.1%, MXWL +1.8%, GLOB +1.6%, DE +1.6%, AXDX +1.4%, WRE +1.2%, STAG +1.2%<br/>Other news:<br/><br/>SNCR +33% (announces closing of convertible preferred stock investment -Siris Capital Group invests in Synchronoss)<br/>CDLX +17.5% (recent IPO extending this week's move higher)<br/>WEN +3.2% (Wendy's increases quarterly dividend 21% from $0.07 to $0.085/share and announce $175 mln share repurchase program)<br/>JACK +2.3% (Barry Rosenstein's Jana Partners discloses increased and active stake)<br/>CTG +2.1% (to commence tender offer to purchase up to 10% of outstanding common stock)<br/>TPC +2% (continues to climb higher in after hours after confirming the Port Authority of New York/New Jersey approved the award of fixed-price contract valued at approximately $1.41 bln to JV)<br/>ICHR +1.2% (announces $50 million share repurchase program)<br/>RIG +0.8% (announces that an agreement has been reached with the incumbent customer to amend the drilling contract on the harsh environment semisubmersible Transocean Leader)<br/><b>Analyst comments:</b><br/><br/>CALA +8.6% (upgraded to Buy from Neutral at Citigroup )<br/>ECA +0.6% (upgraded to Sector Outperform from Sector Perform at Scotia)<br/><b>Gapping down<br/>In reaction to disappointing earnings/guidance:</b><br/><br/>COHU -16.7%, ANET -12.7%, PI -9.9%, SCKT -8.8%, PXLW -7.5%, FLS -6.6%, MDRX -6%, AUY -5.5%, VFC -5.3%, SHAK -4.6%, MCHX -4.3%, WATT -4.2%, LOGM -4%, (also to sell Xively business to Google), PGRE -3.6%, CYTK -3.5%, CPB -3.1%, DLNG -2.5%, EEP -2.3%, PES -1.7%, SAND -1.6%, CUBE -1.5%, NUS -1.3%, GVA -1.2%<br/><b>Other news:</b><br/><br/>APRI -74% (receives Complete Response Letter from FDA for Vitaros, a topical cream for the treatment of erectile dysfunction; FDA cannout approve in present form), NNDM -31.6% (announces proposed public offering of American Depositary Shares)<br/>PCRX -16.1% (FDA Anesthetic and Analgesic Drug Products Advisory Committee did not reach a unanimous decision on the efficacy and safety of the use of EXPAREL as a nerve block to produce regional analgesia )<br/>IO -11.6% (to offer common stock and warrants in underwritten public offering)<br/>TNDM -6.6% ( enters into a distribution agreement with Rubin Medical to commercialize Tandem's t:slim X2 Insulin Pump, insulin cartridges, and t:lock family of Infusion Sets in Sweden, Norway and Denmark)<br/>DM -4.9% (attributed to block trade pricing)<br/>INST -3.9% (prices 2.5 mln shares of common stock at $39.50 per share)<br/>DCIX -3.1% (may be related to Equity Incentive Plan amendment - increasing share amount issuable by 550k)<br/>ETE -1.6% (attributed to block trade pricing)<br/>KYN -0.7% (Kayne Anderson Energy Development Company proposes merger with and into Kayne Anderson MLP Investment Company ), .<br/><br/><b>Analyst comments:</b><br/>N/A.<br/><br/>Briefing.com